Learn More
Medchemexpress LLC Ipatasertib dihydrochloride | 1396257-94-5 | C24H34Cl3N5O2 | 1 G

Supplier: Medchemexpress LLC HY15186A1G
Ipatasertib dihydrochloride is a highly selective and ATP-competitive pan-Akt inhibitor, demonstrating significant selectivity against Akt1, Akt2, and Akt3. It is intended for research use only.
- Highly selective and ATP-competitive pan-Akt inhibitor
- IC50s of 5, 18, and 8 nM for Akt1, Akt2, and Akt3, respectively
- Exhibits over 600-fold and over 100-fold selectivity for Akt1 against PKA and p70S6K
- Effective in xenograft models with Akt activation
- Achieves tumor growth delay, stasis, or regression in vivo
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.